About
Gabriel Levesque Tremblay is a biotech entrepreneur and synthetic biology-trained operator focused on longevity and regenerative medicine. He is CEO and co-founder of HexemBio, which is developing blood stem cell rejuvenation therapies and emerged from stealth with a $10.4 million seed round in April 2026. Earlier, AIChE listed him as Director of Technical Entities & Grants, and Orbillion Bio identified him as a co-founder.
Areas of interest
longevitybiotechsynthetic biologyregenerative medicinestem cell rejuvenationhematopoietic stem cellscell therapyblood cancerscultivated meatsustainable foodsustainability